Medicare Part D: Strategies of the Leading Health Plans - Market Research Reports - Research and Markets

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/344122

Medicare Part D: Strategies of the Leading Health Plans

Description:

Since its creation in 1965, the Medicare program has become a major source of health care coverage for seniors, the disabled, and patients with end-stage renal disease in the United States. Historically, however, Medicare offered only limited coverage of prescription medicines. To improve beneficiaries’ access to outpatient prescription medicines, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (commonly known as the Medicare Modernization Act, or MMA) introduced Medicare Part D--a new outpatient drug benefit that began operation on January 1, 2006. This report analyzes the Medicare Part D strategies of the leading health plans. We begin with a review of the key features of the Part D benefit design and the main sources of Medicare drug benefit coverage. We then examine how six leading health plans--UnitedHealth Group, Humana, WellPoint, MemberHealth, WellCare, and Kaiser Permanente--are approaching Medicare Part D. We conclude with a brief assessment of the outlook for the Medicare prescription drug benefit.

Business Implications
The early success of the leading players in Medicare Part D is attributable not only to their marketing expertise but also to their good fortune in being automatically assigned hundreds of thousands of Medicare-Medicaid dual eligible beneficiaries. They achieved this advantage by setting their premiums below benchmark levels in many states. The Centers for Medicare and Medicaid Services (CMS) will monitor health plans closely and is unlikely to renew contracts with plans it judges to have a deficient benefit design. Furthermore, enrollees could be lured away by other plans that offer more-attractive benefits.
Several leading health plans have openly stated that their longer-term ambition in the Part D market is to transfer as many members as possible from their stand-alone prescription drug plans (PDPs) to their Medicare Advantage (MA) plans, where they can achieve much more substantial margins. If these companies can demonstrate their credentials by means of their PDPs, members may be prepared to sign up for MA plans. As a result, the balance of the Part D market could shift from PDPs to MA plans over time.
An analysis of CMS data shows that 98% of PDPs place a prior authorization or step therapy restriction on at least 1 of the 100 drugs most frequently prescribed to Medicare beneficiaries; 12 plans (1%) restrict more than 40 of these medicines. Sixty-six percent of PDPs have restrictions on 6 or more of the top 100 drugs. On average, Medicare PDPs include 93.5 of the top 100 drugs in their formularies and subject 9.5 of these medicines to prior authorization or step therapy restrictions.
UnitedHealth Group, the leading player in Medicare Part D, has what is generally regarded as the crown jewel of partnerships: an exclusive Part D marketing arrangement with AARP (formerly the American Association of Retired Persons), an organization that represents 35 million seniors in the United States. The AARP product accounts for more than 90% of United’s individual enrollment in Medicare Part D.
Humana, the second-ranked company in this market, owes its early success in the PDP market in large measure to its low-pricing strategy. In 19 states, the company offers the only PDP with a premium of less than $20 per month; in another 14 states, it is one of only two insurers to offer premiums below that price. However, Humana can also offer its members a full array of Medicare products—HMOs, regional and local PPOs, and private fee-for-service plans—at a range of price points and benefit levels.

Contents:

- Overview
- Part D Benefit Design
- Sources of Medicare Drug Benefit Coverage
- Strategies of the Leading Health Plans
UnitedHealth Group
Humana
WellPoint
MemberHealth
WellCare
Kaiser Permanente
- Key Trends and Outlook

List of Figures and Tables
Figure 1 Sources of Medicare Prescription Drug Benefit Coverage or Equivalent, May 7, 2006
Figure 2 Enrollment by Parent Organization in Medicare Prescription Drug Benefit Plans,
Figure 3 Enrollment by Parent Organization in Medicare Advantage Plans with Prescription Drug Benefits, April 27, 2006
Figure 4 Percentage of Medicare Prescription Drug Plans Using Prior Authorization or Step Therapy to Restrict Access to Some of the 100 Drugs Most Frequently Prescribed

Table 1 Key Features of UnitedHealth Group and PacifiCare Stand-Alone Prescription Drug Benefit Plans
Table 2 Key Features of Humana’s Stand-Alone Prescription Drug Benefit Plans
Table 3 Key Features of WellPoint’s Stand-Alone Prescription Drug Benefit Plans
Table 4 Key Features of MemberHealth’s Stand-Alone Prescription Drug Benefit Plans
Table 5 Key Features of WellCare’s Stand-Alone Prescription Drug Benefit Plans
Table 6 Enrollment in Kaiser Permanente’s Medicare Plans, April 2006
Table 7 Key Features of Kaiser Permanente’s Medicare Advantage Plans with Prescription Drug Benefits

Companies Mentioned

Companies Mentioned Inlcude: - Blue Cross Blue Shield of Michigan - Torchmark Corporation - CIGNA - Sierra Health Services - QCC Insurance Company - Longs Drug Stores Corporation - Health Care Service Corporation - Wellmark - SCAN Health Plan - MMM Healthcare - Health Net - HIP, Health Plan of New York - Aetna - Medco Health Solutions - Caremark - Universal American Financial Corporation - Coventry Health Care - WellCare Health Plans - MemberHealth - WellPoint - Humana - UnitedHealth-PacifiCare - Kaiser Permanente - Empire HealthChoice Assurance - NewQuest Health Solutions

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/344122

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 05/09/2008 11:57:17

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
Medicare Part D: Strategies of the Leading Health Plans
Web Address:
http://www.researchandmarkets.com/reports/344122
Office Code:
OCHHGIMQOXZ

Report formats

Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic (PDF) - Single User		€1,043.00

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 05/09/2008 11:57:17

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World